A method of reducing pain includes first identifying a muscle; then identify a related pair of nocipoints on the identified muscle; and applying electrical stimulation to the pair If required, the method may further comprise identifying additional pairs of nocipoints and applying electrical stimulation to them. The stimulation should be from about 1.5 to 3.5 minutes.

Patent
   9205256
Priority
Feb 16 2011
Filed
Feb 15 2012
Issued
Dec 08 2015
Expiry
Feb 15 2032
Assg.orig
Entity
Large
5
3
EXPIRED<2yrs
15. A method, comprising:
identifying an organ;
identifying a related nocipoint on the identified organ;
identifying a second related nocipoint on the identified organ;
attaching electrodes to the pair of nocipoints; and
applying electrical stimulation to the pair of nocipoints, wherein the pair of nocipoints are located at a muscle fiber.
1. A method, comprising:
identifying an organ;
identifying a related nocipoint on the identified organ;
identifying a second related nocipoint on the identified organ;
attaching electrodes to the pair of nocipoints; and
applying electrical stimulation to the pair of nocipoints, wherein the applying electrical stimulation to the pair of nocipoints triggers a reaction of a neuro-immuno cascade.
2. The method of claim 1, wherein the electrical stimulation for each pair of nocipoints ranges from about 1.5 minutes to about 3.5 minutes.
3. The method of claim 1, wherein the electrical stimulation for each pair of nocipoints has a firing minimum threshold of about 10 mV measured subcutaneously at the nerve.
4. The method of claim 1, wherein the electrical stimulation for each pair of nocipoints has an maximum action potential of about 60 mV measured subcutaneously at the nerve.
5. The method of claim 1, wherein the electrical stimulation for each pair of nocipoints enables a C-fiber nerve response.
6. The method of claim 1, wherein the electrical stimulation has a square wave or a sine wave pattern.
7. The method of claim 6, wherein a pulse frequency of the wave is about 20 to about 80 Hz.
8. The method of claim 7, wherein an operating range of pulse amplitude of the stimulation is about 70 to about 130 V.
9. The method of claim 7, wherein an operating range of pulse amplitude of the wave is about 130 to about 170 V.
10. The method of claim 6, wherein the electrical stimulation has a sine wave pattern.
11. The method of claim 6, wherein a pulse frequency of the square wave is about 9 Hz.
12. The method of claim 11, wherein an operating range of pulse amplitude of the square wave is about 130 to about 170 V.
13. The method of claim 1, wherein the nocipoints include nociceptors of muscular sensory nerves.
14. The method of claim 1, wherein the applying electrical stimulation comprises a voltage within a range capable of triggering the reaction of the neuro-immuno cascade.
16. The method of claim 15, wherein the electrical stimulation for each pair of nocipoints ranges from about 1.5 minutes to about 3.5 minutes.
17. The method of claim 15, wherein the electrical stimulation for each pair of nocipoints has a firing minimum threshold of about 10 mV measured subcutaneously at the nerve.
18. The method of claim 15, wherein the electrical stimulation for each pair of nocipoints has an maximum action potential of about 60 mV measured subcutaneously at the nerve.
19. The method of claim 15, wherein the electrical stimulation for each pair of nocipoints enables a C-fiber nerve response.
20. The method of claim 15, wherein the electrical stimulation has a square wave or a sine wave pattern.
21. The method of claim 20, wherein a pulse frequency of the wave is about 20 to about 80 Hz.
22. The method of claim 21, wherein an operating range of pulse amplitude of the stimulation is about 70 to about 130 V.
23. The method of claim 21, wherein an operating range of pulse amplitude of the wave is about 130 to about 170 V.
24. The method of claim 20, wherein the electrical stimulation has a sine wave pattern.
25. The method of claim 20, wherein a pulse frequency of the square wave is about 9 Hz.
26. The method of claim 25, wherein an operating range of pulse amplitude of the square wave is about 130 to about 170 V.
27. The method of claim 15, wherein the nocipoints include nociceptors of muscular sensory nerves.
28. The method of claim 15, wherein the applying electrical stimulation to the pair of nocipoints triggers a reaction of a neuro-immuno cascade.
29. The method of claim 28, wherein the applying electrical stimulation comprises a voltage within a range capable of triggering the reaction of the neuro-immuno cascade.

This application claims priority to and incorporates by reference U.S. Patent Application No. 61/443,258 filed Feb. 16, 2011.

At least one embodiment of the present invention pertains to medical procedures and more particularly, but not exclusively, to reducing pain through electrical stimulation of Nocipoints.

Chronic skeletal-muscular pain costs the US $200+B a year and increasing in terms of loss of time and medical expenses according to the 2011 CDC report. However, they are merely the manifestation of the underlying causes—skeletal-muscular injuries or pinched nerves.

Skeletal-muscular injuries from car accidents, sports, exercises, sudden movement, wrong postures or sometime unknown reasons are the major cause of such pain. Standard self-care process includes cold/heat pads and good rest for a period of time. In many cases, especially in acute cases, the body recovers; the muscle injury heals, and the pain disappears. Unfortunately, many people, 112 million in the US, get stuck with chronic pain, according to the CDC report.

Pinched nerves at spinal cord cause pain syndromes or loss of motor control at extremities (arms and legs). When a motor nerve is pinched, the patient experiences weak muscle response or even loss of motor control of the affected arm/leg. When a sensory nerve is pinched, the patient experiences tingling sensation, numbness in certain areas of the affected arm or leg. Herniated discs are often cited as the cause of the problem in radiological interpretation of CT scans. However, it is misleading because (1) most herniated discs do not even touch the nearby nerve and thus not necessarily cause any pain, and (2) herniated discs occur even in normal people with no pain or known injury. Most pinched nerve problems, as our clinical study indicates, are actually caused by injuries of the muscle groups that support and balance the spine. When the injuries of those corresponding muscles, mostly near the neck or the lower back, are healed, the pinched nerve problem and any associated pain disappear as well.

Standard treatments for chronic pain typically include physical therapy, pain medication, epidural injection of steroids, and surgeries. The treatment process is long and ineffective: Majority of the patients had little or no improvement after six months or longer of various therapies. The epidural injection is useful to reduce neural inflammation. However, most of the chronics pains described above are not neural inflammation. Thus, majority of patients either experience no improvement or temporary improvement with a rebound in a few days or few months when the epidural steroid wears off. In addition, due to the serious side-effect of steroids, epidural injection can only be used for several times. The prognosis of surgery was even less positive. Most of patients who undergo such invasive surgeries on and after six-month recovery periods found that their conditions are not better or even worse than before the surgery. Pain medications, including both prescription anti-inflammatory drugs and over-the-counter analgesic medicine, are often used to relieve the pain temporarily and reduce the inflammation hoping that the body will heal the injury itself once inflammation is reduced. For some patients with acute injury, the pain medication will bridge them through the recovery process with less or no pain. Unfortunately, chronic pain patients usually experience temporary relief with medications. The pain returns within hours after medication is taken. In essence, majority of people who have chronic pain would go through multiple years of treatments without a permanent cure.

Based on extensive medical and biological research, when deep (muscle) tissues are injured, it triggers a cascade of the healing process mediated by innate immune system: The injured muscle/soft tissue triggers the release of cytokines (chemicals carry signals to promote or inhibit immune responses), which recruit the innate immune cells (e.g., macrophages) to take away the dead and injured tissue cells. Macrophages in turn release other cytokines (e.g., IGF-1) and trigger the cascade of the muscle tissue repair and regeneration. In normal cases, the immune system eventually heals the muscle. Unfortunately, the process often gets interrupted and never completes. Interruptive processes include:

The clinical study conducted in the application firmly implicates that nociceptors (i.e., pain receptors) of the muscle sensory nerve (esp., the C-fiber) participate (respond) in the healing process and ensure the positive signaling to the healing process and that the specific threshold-gated electrical stimulation procedure described in this application triggers the neural signaling and thus the healing process on the immune system side, based on the thousands of cases in which muscle injuries/pains recovered within a few hours to a few days after the procedure.

One or more embodiments of the present invention are illustrated by way of example and not limitation in the figures of the accompanying drawings, in which like references indicate similar elements.

FIG. 1 illustrates a 59 year old patient injured his back after trying to pick up a heavy box. Couldn't bend more than 20 degrees. Had lower back pain.

FIG. 2 illustrates locating muscle group(s) responsible for the pain of the example patient.

FIG. 3 illustrates an example of locating a “Nocipoint.”

FIG. 4 illustrates tracing anatomically to find the second Nocipoint.

FIG. 5 illustrates an example case repeating the procedure on other pairs of Nocipoints.

FIG. 6 illustrates within 25 minutes, the patient recovered after the first treatment with full motion range. No more back pain since then.

FIG. 7 is a chart illustrating relative pain levels BEFORE and AFTER the Nocipoint Therapy.

FIG. 8 illustrates a patient before treatment.

FIG. 9 illustrates the patient after treatment.

Nocipoint Stimulation Therapy—A Threshold-Gated Electrical Neuro-Immuno-Stimulation:

The Nocipoint Stimulation Therapy is a process using electrical stimulation in a precise manner that activates the complete healing of (1) muscle injury with associated local pain, and (2) muscle injury that causes pinched nerve and indirectly causes remote pains and/or loss of motor control at the extremities (legs, arms) in a short time:

Steps:

Pulse Operating range of
Wave pattern frequency pulse amplitude
Square wave/Sine wave  9 Hz 130 V-170 V
Square wave 20 Hz 70 V-95 V

The Treatment Procedure:

The patients were given the Nocipoint Therapy: Electrically stimulate certain stimulation points that were anatomically relevant to injured tissues/sites with controlled timing, strength, dosing, etc. Because most patients had multiple problem areas, each session typically lasted for 1.5 hours.

The results (based on a study of 64 chronic pain patients):

100% patients recovered with full range of motion and only less than 10% reports Level 1 or 2 out of 10 remaining pain. 89% of patients recovered in 1-4 sessions. Full recovery is defined as (1) gaining full range of motion (age appropriate) and (2) persisting function for at least one month without recurring pains.

Recovered in # of Remaining pain (×/10) level
sessions # of patients percentage when treatment stopped
1 7 10.9% 0-1
2 16 25.0% 0-not noticable
3 19 29.7% 0-not noticable
4 15 23.4% not noticable-1
 5+ 7 10.9% 1-2 **
64 total

Most patients experienced substantial or complete recovery of muscle function in the first one or two treatments. Later sessions were typically dealing with secondary/other pains that were not in the patients' chief complaint initially. (That is, when the primary problem is cured, the patient's perception starts to notice secondary and other pains.)

Arm and hand pains typically involve more muscle groups and often take longer time than neck/lower back pains.

** People who had extensive tissue damages required multiple sessions/more time to cover all the damaged tissues/muscle groups. Some patients who went through 4 or 5+ sessions stopped coming because they were happy with the substantial improvements.

Control-Test Analysis

Chronic pain patients typically have persistent pain for months or years, with other conventional treatment/therapy (See FIG. 1). The patients who received the Nocipoint Therapy experienced substantial pain relief and regained function immediately after the treatment. Unlike all prior arts, the recovery persisted. The control in this study is the historical pain level before the treatment, while the test is the pain level afterward the treatment (in the AFTER scenario).

All treatments were done within one to several hours accumulatively, spreading over one or a few sessions. The gap between sessions has minor impact on recovery, positive or negative. That is, patients technically can complete all sessions consecutively in a short period.

Patients usually experienced immediate improvement/cure when the correct Nocipoints are stimulated. This contrasts the 1-2 years of standard pain management protocol. The Nocipoint Therapy is precise, reproducible, and with near-perfect success rate.

Elimination of the placebo effect: During a session, if the points for stimulation were off by a little from the intended points mistakenly (e.g., by ½ inch), or by a lot intentionally, the patient could tell and would instantly indicate the lack of improvement. Correcting the stimulation location to the right Nocipoints will enable instant result.

After each session, the patients were instructed to go easy on exercises with the newly recovered muscles for a few days or a week for seniors, to prevent new injuries before the tissue gains enough strength.

In sum, the procedure cures pains permanently and persistently. More importantly, it heals injured tissues and restores functions. It is repeatable and the same results occur in nearly all cases.

A recent example: (with patient's permission):

The patient is 59, who injured his lower back a week before the treatment while picking up a heavy box. Had been in pain and had to roll off the bed every day. Worn waist support all days to avoid pain.

Before the treatment: See FIG. 8: the maximum angle he could bend without waist support)

After a 25-minute treatment: Full range of motion recovered. No pain since. See FIG. 9.

Note that any and all of the embodiments described above can be combined with each other, except to the extent that it may be stated otherwise above or to the extent that any such embodiments might be mutually exclusive in function and/or structure.

Although the present invention has been described with reference to specific exemplary embodiments, it will be recognized that the invention is not limited to the embodiments described, but can be practiced with modification and alteration within the spirit and scope of the appended claims. Accordingly, the specification and drawings are to be regarded in an illustrative sense rather than a restrictive sense.

Koo, Charles C.

Patent Priority Assignee Title
10213602, Jan 13 2015 THERANICA BIO-ELECTRONICS LTD ; THERANICA BIO-ELECTRONIC LTD Treatment of headaches by electrical stimulation
10994135, Jan 13 2015 THERANICA BIO-ELECTRONICS LTD. Treatment of headaches by electrical stimulation
11167135, May 21 2017 THERANICA BIO-ELECTRONICS LTD Apparatus for providing pain relief therapy
11357980, Sep 29 2016 THERANICA BIO-ELECTRONICS LTD Apparatus for applying an electrical signal to a subject
11904163, May 21 2017 THERANICA BIO-ELECTRONICS LTD. Apparatus for providing pain relief therapy
Patent Priority Assignee Title
5107835, May 22 1989 Physiodynamics; PHYSIODYNAMICS, A COMPANY OF CO Electrotherapeutic treatment
20030130706,
20100030299,
Executed onAssignorAssigneeConveyanceFrameReelDoc
Date Maintenance Fee Events
Jun 05 2019M3551: Payment of Maintenance Fee, 4th Year, Micro Entity.
Jun 06 2019BIG: Entity status set to Undiscounted (note the period is included in the code).
Jun 06 2019M1559: Payment of Maintenance Fee under 1.28(c).
Dec 13 2019PTGR: Petition Related to Maintenance Fees Granted.
Jul 31 2023REM: Maintenance Fee Reminder Mailed.
Jan 15 2024EXP: Patent Expired for Failure to Pay Maintenance Fees.


Date Maintenance Schedule
Dec 08 20184 years fee payment window open
Jun 08 20196 months grace period start (w surcharge)
Dec 08 2019patent expiry (for year 4)
Dec 08 20212 years to revive unintentionally abandoned end. (for year 4)
Dec 08 20228 years fee payment window open
Jun 08 20236 months grace period start (w surcharge)
Dec 08 2023patent expiry (for year 8)
Dec 08 20252 years to revive unintentionally abandoned end. (for year 8)
Dec 08 202612 years fee payment window open
Jun 08 20276 months grace period start (w surcharge)
Dec 08 2027patent expiry (for year 12)
Dec 08 20292 years to revive unintentionally abandoned end. (for year 12)